Eplerenone/furosemide/tolvaptanLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1934卷 / 1期

关键词：

D O I：

10.1007/s40278-022-28566-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：185 / 185

相关论文

共 50 条

[1] Furosemide/spironolactone/tolvaptanLack of efficacy: case report
Reactions Weekly, 2023, 1980 (1) : 194 - 194
[2] Furosemide/spironolactone/tolvaptanLack of efficacy: case report
Reactions Weekly, 2021, 1854 (1) : 160 - 160
[3] Furosemide/spironolactone/tolvaptanLack of efficacy: case report
Reactions Weekly, 2022, 1909 (1) : 258 - 258
[4] Atrial natriuretic peptide/furosemide/tolvaptanLack of efficacy: case report
Reactions Weekly, 2021, 1882 (1) : 84 - 84
[5] Dexamethasone/furosemide/tolvaptanLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1928 (1) : 154 - 154
[6] Azosemide/furosemide/tolvaptanLack of efficacy: 2 case reports
Reactions Weekly, 2022, 1914 (1) : 114 - 114
[7] TolvaptanLack of efficacy: case report
Reactions Weekly, 2021, 1838 (1) : 502 - 502
[8] Furosemide/sodium-chloride/tolvaptanLack of efficacy
Reactions Weekly, 2024, 2006 (1) : 284 - 284
[9] Eplerenone/furosemide/linagliptinHypoglycaemia and hypotension: case report
Reactions Weekly, 2023, 1940 (1) : 188 - 188
[10] Cisplatin/etoposide/tolvaptanLack of efficacy: case report
Reactions Weekly, 2022, 1936 (1) : 156 - 156

← 1 2 3 4 5 →